Skip to main content
logo
Vivo Bio Tech Limited (BOM:511509)
India flag India · Delayed Price · Currency is INR
19.31
-0.02 (-0.10%)
At close: Aug 21, 2026

Vivo Bio Tech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
551.03533.35466.73454.51522.3513.91
Revenue Growth
12.34%14.27%2.69%-12.98%1.63%-0.74%
Gross Profit
466.26452.08405.65412.99451.64397.41
Operating Income
94.98108.22114.93118122.3683.67
Net Income
-28.58-17.0972.8325.2626.4922.02
Earnings Per Share
-1.29-0.824.761.511.781.56
EPS Growth
--215.23%-15.17%14.33%-62.84%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14.3614.3612.8113.913.7517.14
Total Debt
673.81673.81540.25730.64623.96674.39
Net Cash (Debt)
-659.45-659.45-527.44-716.74-610.21-657.25
Net Cash Growth
------
Net Cash Per Share
-29.73-31.64-34.49-42.97-41.16-46.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-349.31118.28155.22148.34166.42
Capital Expenditures
--374.38-222.7-79.5-39.98-511.12
Free Cash Flow
--25.07-104.4275.72108.36-344.7
Free Cash Flow Growth
----30.12%--

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
84.61%84.76%86.91%90.86%86.47%77.33%
Operating Margin
17.24%20.29%24.62%25.96%23.43%16.28%
Pretax Margin
6.66%9.02%18.84%8.93%8.85%8.70%
Profit Margin
-5.19%-3.20%15.60%5.56%5.07%4.28%
FCF Margin
--4.70%-22.37%16.66%20.75%-67.07%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--8.0125.2910.8625.69
P/FCF Ratio
---8.442.65-
PS Ratio
0.780.881.251.410.551.10